-+ 0.00%
-+ 0.00%
-+ 0.00%

Eledon Pharma Q2 EPS $(0.27) Misses $(0.16) Estimate

Benzinga·08/13/2026 20:30:25
Listen to the news
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.16) by 68.75 percent. This is a 107.69 percent decrease over losses of $(0.13) per share from the same period last year.